Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Vedistry Liver Care is an approved Ayurvedic multi-herb formulation developed and manufactured by Charak Pharma. It is marketed under the Vedistry brand and contains 13 Ayurvedic herbs, with key active ingredients including Bhumyamalaki (Phyllanthus niruri), Kalmegh (Andrographis paniculata), Punarnava (Boerhavia diffusa), Eranda (Ricinus communis), Kutaki, Sharapunkha, and Amalaki. The product is indicated for liver health, specifically targeting fatty liver (Non-Alcoholic Fatty Liver Disease/NAFLD), elevated liver enzymes (SGPT/SGOT), liver detoxification, and protection against liver damage caused by alcohol, drugs, and infections. It also supports bile flow, fat metabolism, digestion, and liver cell regeneration. Backed by a clinical trial (CTRI/2025/02/080633), it has demonstrated a 22% reduction in fatty liver and a 10.41% reduction in liver fibrosis over 90 days.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Vedistry Liver Care.